Warren Jones, PhD
Biomarker Research Lead
Emory University
Dr. Jones completed his doctorate in neuroscience at Yale University. His research focuses on developing objective digital biomarkers for early identification and assessment of autism, to reduce the age of diagnosis and to provide objective measurements of treatment progress.
Dr. Jones founded EarliPoint Health with Dr. Ami Klin in order to translate laboratory science into actionable clinical tools. This led, in 2023, to FDA clearance of the first objective tool to aid in the diagnosis and assessment of autism in children 16-30 months of age: EarliPoint. Most recently, EarliPoint received FDA clearance for diagnosis and assessment of autism up until age 8 years.